Skip to main content
Erschienen in: The International Journal of Cardiovascular Imaging 2/2015

01.02.2015 | Original Paper

2D phase contrast blood flow velocity measurements of the thoracic vasculature: comparison of the effect of gadofosveset trisodium and gadopentetate dimeglumine

verfasst von: Marcus R. Makowski, Andrea J. Wiethoff, Hans U. Ebersberger, René M. Botnar, Reza Razavi, Tobias Schaeffter, Gerald F. Greil

Erschienen in: The International Journal of Cardiovascular Imaging | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

The aim of this prospective study is to compare the performance of 2D time-resolved phase-contrast (PC) MRI prior to and after the administration of an intravascular (gadofosveset-trisodium) and extravascular (gadopentetate-dimeglumine) contrast agent in the same patient in the cardiovascular system. This study was approved by the ethics committee (Study-Number-07/Q0704/2) and registered with the MedicinesAndHealthcareProductsRegulatoryAgency (MHRA-Study-Number-28482/0002/001-0001, EudraCT-Number-2006-007042). All patients signed an informed consent. 20 patients were examined using a 1.5T MR-scanner and 32-channel-coil-technology. Gadopentetate-dimeglumine (GdD) and gadofosveset-trisodium (GdT) were administered in the same patient on consecutive days. Image quality, velocity-to-noise-ratios (VNRs) and standard-deviation of blood-flow-velocities (phase-noise) were compared between GdT, GdD and non-contrast-enhanced imaging. On both days pre- and post-contrast-scans were performed. The administration of GdT significantly improved the delineation of the perfused lumen and the VNR compared to GdD and non-contrast-enhanced imaging. Standard deviations of through-plane and in-plane velocity-measurements (phase-noise) were significantly reduced after GdT administration (p < 0.05). No significant differences (p > 0.05) were measured regarding absolute flow values prior to and after the administration of GdD and GdT. PC flow imaging benefits from the administration of an intravascular contrast agent by improving the delineation of the perfused lumen and reducing phase noise in flow measurements.
Literatur
1.
Zurück zum Zitat Greil GF, Geva T, Maier SE, Powell AJ (2002) Effect of acquisition parameters on the accuracy of velocity encoded cine magnetic resonance imaging blood flow measurements. J Magn Reson Imaging 15(1):47–54CrossRefPubMed Greil GF, Geva T, Maier SE, Powell AJ (2002) Effect of acquisition parameters on the accuracy of velocity encoded cine magnetic resonance imaging blood flow measurements. J Magn Reson Imaging 15(1):47–54CrossRefPubMed
2.
Zurück zum Zitat Frayne R, Steinman DA, Ethier CR, Rutt BK (1995) Accuracy of MR phase contrast velocity measurements for unsteady flow. J Magn Reson Imaging 5(4):428–431CrossRefPubMed Frayne R, Steinman DA, Ethier CR, Rutt BK (1995) Accuracy of MR phase contrast velocity measurements for unsteady flow. J Magn Reson Imaging 5(4):428–431CrossRefPubMed
3.
Zurück zum Zitat Kondo C, Caputo GR, Semelka R, Foster E, Shimakawa A, Higgins CB (1991) Right and left ventricular stroke volume measurements with velocity-encoded cine MR imaging: in vitro and in vivo validation. AJR Am J Roentgenol 157(1):9–16CrossRefPubMed Kondo C, Caputo GR, Semelka R, Foster E, Shimakawa A, Higgins CB (1991) Right and left ventricular stroke volume measurements with velocity-encoded cine MR imaging: in vitro and in vivo validation. AJR Am J Roentgenol 157(1):9–16CrossRefPubMed
4.
Zurück zum Zitat Mostbeck GH, Caputo GR, Higgins CB (1992) MR measurement of blood flow in the cardiovascular system. AJR Am J Roentgenol 159(3):453–461CrossRefPubMed Mostbeck GH, Caputo GR, Higgins CB (1992) MR measurement of blood flow in the cardiovascular system. AJR Am J Roentgenol 159(3):453–461CrossRefPubMed
5.
Zurück zum Zitat Kilner PJ, Firmin DN, Rees RS et al (1991) Valve and great vessel stenosis: assessment with MR jet velocity mapping. Radiology 178(1):229–235CrossRefPubMed Kilner PJ, Firmin DN, Rees RS et al (1991) Valve and great vessel stenosis: assessment with MR jet velocity mapping. Radiology 178(1):229–235CrossRefPubMed
6.
Zurück zum Zitat Sakuma H, Kawada N, Takeda K, Higgins CB (1999) MR measurement of coronary blood flow. J Magn Reson Imaging 10(5):728–733CrossRefPubMed Sakuma H, Kawada N, Takeda K, Higgins CB (1999) MR measurement of coronary blood flow. J Magn Reson Imaging 10(5):728–733CrossRefPubMed
7.
Zurück zum Zitat Sakuma H, Kawada N, Takeda K, Higgins CB (1999) MR measurement of coronary blood flow. J Magn Reson Imaging 10(5):728–733CrossRefPubMed Sakuma H, Kawada N, Takeda K, Higgins CB (1999) MR measurement of coronary blood flow. J Magn Reson Imaging 10(5):728–733CrossRefPubMed
8.
Zurück zum Zitat Hays AG, Hirsch GA, Kelle S, Gerstenblith G, Weiss RG, Stuber M (2010) Noninvasive visualization of coronary artery endothelial function in healthy subjects and in patients with coronary artery disease. J Am Coll Cardiol 56(20):1657–1665CrossRefPubMed Hays AG, Hirsch GA, Kelle S, Gerstenblith G, Weiss RG, Stuber M (2010) Noninvasive visualization of coronary artery endothelial function in healthy subjects and in patients with coronary artery disease. J Am Coll Cardiol 56(20):1657–1665CrossRefPubMed
9.
Zurück zum Zitat Lee VS, Spritzer CE, Carroll BA et al (1997) Flow quantification using fast cine phase-contrast MR imaging, conventional cine phase-contrast MR imaging, and Doppler sonography: in vitro and in vivo validation. AJR Am J Roentgenol 169(4):1125–1131CrossRefPubMed Lee VS, Spritzer CE, Carroll BA et al (1997) Flow quantification using fast cine phase-contrast MR imaging, conventional cine phase-contrast MR imaging, and Doppler sonography: in vitro and in vivo validation. AJR Am J Roentgenol 169(4):1125–1131CrossRefPubMed
10.
Zurück zum Zitat Lauffer RB, Parmelee DJ, Dunham SU et al (1998) MS-325: albumin-targeted contrast agent for MR angiography. Radiology 207(2):529–538CrossRefPubMed Lauffer RB, Parmelee DJ, Dunham SU et al (1998) MS-325: albumin-targeted contrast agent for MR angiography. Radiology 207(2):529–538CrossRefPubMed
11.
Zurück zum Zitat Lotz J, Doker R, Noeske R et al (2005) In vitro validation of phase-contrast flow measurements at 3 T in comparison to 1.5 T: precision, accuracy, and signal-to-noise ratios. J Magn Reson Imaging 21(5):604–610CrossRefPubMed Lotz J, Doker R, Noeske R et al (2005) In vitro validation of phase-contrast flow measurements at 3 T in comparison to 1.5 T: precision, accuracy, and signal-to-noise ratios. J Magn Reson Imaging 21(5):604–610CrossRefPubMed
12.
Zurück zum Zitat Saeed M, Wendland MF, Higgins CB (2000) Blood pool MR contrast agents for cardiovascular imaging. J Magn Reson Imaging 12(6):890–898CrossRefPubMed Saeed M, Wendland MF, Higgins CB (2000) Blood pool MR contrast agents for cardiovascular imaging. J Magn Reson Imaging 12(6):890–898CrossRefPubMed
13.
Zurück zum Zitat Schoenberg SO, Just A, Bock M, Knopp MV, Persson PB, Kirchheim HR (1997) Noninvasive analysis of renal artery blood flow dynamics with MR cine phase-contrast flow measurements. Am J Physiol 272(5 Pt 2):H2477–H2484PubMed Schoenberg SO, Just A, Bock M, Knopp MV, Persson PB, Kirchheim HR (1997) Noninvasive analysis of renal artery blood flow dynamics with MR cine phase-contrast flow measurements. Am J Physiol 272(5 Pt 2):H2477–H2484PubMed
14.
Zurück zum Zitat Heverhagen JT, Hoppe M, Klose KJ, Wagner HJ (2002) Does the application of gadolinium-DTPA have an impact on magnetic resonance phase contrast velocity measurements? Results from an in vitro study. Eur J Radiol 44(1):65–69CrossRefPubMed Heverhagen JT, Hoppe M, Klose KJ, Wagner HJ (2002) Does the application of gadolinium-DTPA have an impact on magnetic resonance phase contrast velocity measurements? Results from an in vitro study. Eur J Radiol 44(1):65–69CrossRefPubMed
15.
Zurück zum Zitat Bass JC, Prince MR, Londy FJ, Chenevert TL (1997) Effect of gadolinium on phase-contrast MR angiography of the renal arteries. AJR Am J Roentgenol 168(1):261–266CrossRefPubMed Bass JC, Prince MR, Londy FJ, Chenevert TL (1997) Effect of gadolinium on phase-contrast MR angiography of the renal arteries. AJR Am J Roentgenol 168(1):261–266CrossRefPubMed
16.
Zurück zum Zitat Hartmann M, Wiethoff AJ, Hentrich HR, Rohrer M (2006) Initial imaging recommendations for Vasovist angiography. Eur Radiol 16(Suppl 2):B15–B23CrossRefPubMed Hartmann M, Wiethoff AJ, Hentrich HR, Rohrer M (2006) Initial imaging recommendations for Vasovist angiography. Eur Radiol 16(Suppl 2):B15–B23CrossRefPubMed
17.
Zurück zum Zitat Stalder AF, Dong Z, Yang Q et al (2012) Four-dimensional flow-sensitive MRI of the thoracic aorta: 12- versus 32-channel coil arrays. J Magn Reson Imaging 35(1):190–195CrossRefPubMed Stalder AF, Dong Z, Yang Q et al (2012) Four-dimensional flow-sensitive MRI of the thoracic aorta: 12- versus 32-channel coil arrays. J Magn Reson Imaging 35(1):190–195CrossRefPubMed
18.
Zurück zum Zitat Frydrychowicz A, Stalder AF, Russe MF et al (2009) Three-dimensional analysis of segmental wall shear stress in the aorta by flow-sensitive four-dimensional-MRI. J Magn Reson Imaging 30(1):77–84CrossRefPubMed Frydrychowicz A, Stalder AF, Russe MF et al (2009) Three-dimensional analysis of segmental wall shear stress in the aorta by flow-sensitive four-dimensional-MRI. J Magn Reson Imaging 30(1):77–84CrossRefPubMed
19.
Zurück zum Zitat Frydrychowicz A, Schlensak C, Stalder A et al (2007) Ascending-descending aortic bypass surgery in aortic arch coarctation: four-dimensional magnetic resonance flow analysis. J Thorac Cardiovasc Surg 133(1):260–262CrossRefPubMed Frydrychowicz A, Schlensak C, Stalder A et al (2007) Ascending-descending aortic bypass surgery in aortic arch coarctation: four-dimensional magnetic resonance flow analysis. J Thorac Cardiovasc Surg 133(1):260–262CrossRefPubMed
20.
Zurück zum Zitat Nett EJ, Johnson KM, Frydrychowicz A et al (2012) Four-dimensional phase contrast MRI with accelerated dual velocity encoding. J Magn Reson Imaging 35(6):1462–1471CrossRefPubMedCentralPubMed Nett EJ, Johnson KM, Frydrychowicz A et al (2012) Four-dimensional phase contrast MRI with accelerated dual velocity encoding. J Magn Reson Imaging 35(6):1462–1471CrossRefPubMedCentralPubMed
21.
Zurück zum Zitat Wong J, Mathur S, Giese D et al (2012) Analysis of aortopulmonary window using cardiac magnetic resonance imaging. Circulation 126(15):e228–e229CrossRefPubMed Wong J, Mathur S, Giese D et al (2012) Analysis of aortopulmonary window using cardiac magnetic resonance imaging. Circulation 126(15):e228–e229CrossRefPubMed
22.
Zurück zum Zitat Markl M, Kilner PJ, Ebbers T (2011) Comprehensive 4D velocity mapping of the heart and great vessels by cardiovascular magnetic resonance. J Cardiovasc Magn Reson 13:7CrossRefPubMedCentralPubMed Markl M, Kilner PJ, Ebbers T (2011) Comprehensive 4D velocity mapping of the heart and great vessels by cardiovascular magnetic resonance. J Cardiovasc Magn Reson 13:7CrossRefPubMedCentralPubMed
23.
Zurück zum Zitat Pruessmann KP, Weiger M, Scheidegger MB, Boesiger P (1999) SENSE: sensitivity encoding for fast MRI. Magn Reson Med 42(5):952–962CrossRefPubMed Pruessmann KP, Weiger M, Scheidegger MB, Boesiger P (1999) SENSE: sensitivity encoding for fast MRI. Magn Reson Med 42(5):952–962CrossRefPubMed
24.
Zurück zum Zitat Lee AT, Pike GB, Pelc NJ (1995) Three-point phase-contrast velocity measurements with increased velocity-to-noise ratio. Magn Reson Med 33(1):122–126CrossRefPubMed Lee AT, Pike GB, Pelc NJ (1995) Three-point phase-contrast velocity measurements with increased velocity-to-noise ratio. Magn Reson Med 33(1):122–126CrossRefPubMed
25.
Zurück zum Zitat Greil GF, Powell AJ, Gildein HP, Geva T (2002) Gadolinium-enhanced three-dimensional magnetic resonance angiography of pulmonary and systemic venous anomalies. J Am Coll Cardiol 39(2):335–341CrossRefPubMed Greil GF, Powell AJ, Gildein HP, Geva T (2002) Gadolinium-enhanced three-dimensional magnetic resonance angiography of pulmonary and systemic venous anomalies. J Am Coll Cardiol 39(2):335–341CrossRefPubMed
26.
Zurück zum Zitat McConnell MV, Khasgiwala VC, Savord BJ et al (1997) Comparison of respiratory suppression methods and navigator locations for MR coronary angiography. AJR Am J Roentgenol 168(5):1369–1375CrossRefPubMed McConnell MV, Khasgiwala VC, Savord BJ et al (1997) Comparison of respiratory suppression methods and navigator locations for MR coronary angiography. AJR Am J Roentgenol 168(5):1369–1375CrossRefPubMed
27.
Zurück zum Zitat Stuber M, Botnar RM, Danias PG et al (1999) Contrast agent-enhanced, free-breathing, three-dimensional coronary magnetic resonance angiography. J Magn Reson Imaging 10(5):790–799CrossRefPubMed Stuber M, Botnar RM, Danias PG et al (1999) Contrast agent-enhanced, free-breathing, three-dimensional coronary magnetic resonance angiography. J Magn Reson Imaging 10(5):790–799CrossRefPubMed
28.
Zurück zum Zitat Taylor AM, Panting JR, Keegan J et al (1999) Use of the intravascular contrast agent NC100150 injection in spin-echo and gradient-echo imaging of the heart. J Cardiovasc Magn Reson 1(1):23–32CrossRefPubMed Taylor AM, Panting JR, Keegan J et al (1999) Use of the intravascular contrast agent NC100150 injection in spin-echo and gradient-echo imaging of the heart. J Cardiovasc Magn Reson 1(1):23–32CrossRefPubMed
29.
Zurück zum Zitat Gerretsen SC, Versluis B, Bekkers SC, Leiner T (2008) Cardiac cine MRI: comparison of 1.5 T, non-enhanced 3.0 T and blood pool enhanced 3.0 T imaging. Eur J Radiol 65(1):80–85CrossRefPubMed Gerretsen SC, Versluis B, Bekkers SC, Leiner T (2008) Cardiac cine MRI: comparison of 1.5 T, non-enhanced 3.0 T and blood pool enhanced 3.0 T imaging. Eur J Radiol 65(1):80–85CrossRefPubMed
30.
Zurück zum Zitat Wagenseil JE, Johansson LO, Lorenz CH (1999) Characterization of t1 relaxation and blood-myocardial contrast enhancement of NC100150 injection in cardiac MRI. J Magn Reson Imaging 10(5):784–789CrossRefPubMed Wagenseil JE, Johansson LO, Lorenz CH (1999) Characterization of t1 relaxation and blood-myocardial contrast enhancement of NC100150 injection in cardiac MRI. J Magn Reson Imaging 10(5):784–789CrossRefPubMed
31.
Zurück zum Zitat Huber S, Muthupillai R, Mojibian H, Cheong B, Kouwenhoven M, Flamm SD (2008) Rapid assessment of regional and global left ventricular function using three-dimensional k-t BLAST imaging. Magn Reson Imaging 26(6):727–738CrossRefPubMed Huber S, Muthupillai R, Mojibian H, Cheong B, Kouwenhoven M, Flamm SD (2008) Rapid assessment of regional and global left ventricular function using three-dimensional k-t BLAST imaging. Magn Reson Imaging 26(6):727–738CrossRefPubMed
32.
Zurück zum Zitat Ritter CO, Wilke A, Wichmann T, Beer M, Hahn D, Kostler H (2011) Comparison of intravascular and extracellular contrast media for absolute quantification of myocardial rest-perfusion using high-resolution MRI. J Magn Reson Imaging 33(5):1047–1051CrossRefPubMed Ritter CO, Wilke A, Wichmann T, Beer M, Hahn D, Kostler H (2011) Comparison of intravascular and extracellular contrast media for absolute quantification of myocardial rest-perfusion using high-resolution MRI. J Magn Reson Imaging 33(5):1047–1051CrossRefPubMed
33.
Zurück zum Zitat Nezafat R, Herzka D, Stehning C, Peters DC, Nehrke K, Manning WJ (2008) Inflow quantification in three-dimensional cardiovascular MR imaging. J Magn Reson Imaging 28(5):1273–1279CrossRefPubMed Nezafat R, Herzka D, Stehning C, Peters DC, Nehrke K, Manning WJ (2008) Inflow quantification in three-dimensional cardiovascular MR imaging. J Magn Reson Imaging 28(5):1273–1279CrossRefPubMed
34.
Zurück zum Zitat Kozerke S, Tsao J (2004) Reduced data acquisition methods in cardiac imaging. Top Magn Reson Imaging 15(3):161–168CrossRefPubMed Kozerke S, Tsao J (2004) Reduced data acquisition methods in cardiac imaging. Top Magn Reson Imaging 15(3):161–168CrossRefPubMed
35.
Zurück zum Zitat Bock J, Frydrychowicz A, Stalder AF et al (2010) 4D phase contrast MRI at 3 T: effect of standard and blood-pool contrast agents on SNR, PC-MRA, and blood flow visualization. Magn Reson Med 63(2):330–338CrossRefPubMed Bock J, Frydrychowicz A, Stalder AF et al (2010) 4D phase contrast MRI at 3 T: effect of standard and blood-pool contrast agents on SNR, PC-MRA, and blood flow visualization. Magn Reson Med 63(2):330–338CrossRefPubMed
36.
Zurück zum Zitat Frydrychowicz A, Arnold R, Harloff A et al (2008) Images in cardiovascular medicine. In vivo 3-dimensional flow connectivity mapping after extracardiac total cavopulmonary connection. Circulation 118(2):e16–e17CrossRefPubMed Frydrychowicz A, Arnold R, Harloff A et al (2008) Images in cardiovascular medicine. In vivo 3-dimensional flow connectivity mapping after extracardiac total cavopulmonary connection. Circulation 118(2):e16–e17CrossRefPubMed
Metadaten
Titel
2D phase contrast blood flow velocity measurements of the thoracic vasculature: comparison of the effect of gadofosveset trisodium and gadopentetate dimeglumine
verfasst von
Marcus R. Makowski
Andrea J. Wiethoff
Hans U. Ebersberger
René M. Botnar
Reza Razavi
Tobias Schaeffter
Gerald F. Greil
Publikationsdatum
01.02.2015
Verlag
Springer Netherlands
Erschienen in
The International Journal of Cardiovascular Imaging / Ausgabe 2/2015
Print ISSN: 1569-5794
Elektronische ISSN: 1875-8312
DOI
https://doi.org/10.1007/s10554-014-0565-y

Weitere Artikel der Ausgabe 2/2015

The International Journal of Cardiovascular Imaging 2/2015 Zur Ausgabe

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.